Identifying monogenic diabetes in a pediatric cohort with presumed type 1 diabetes

Pediatric Diabetes

Volumn 16, Issue 3, 2015, Pages 227-233

  Gandica, Rachelle G ^a   Chung, Wendy K ^a   Deng, Liyong ^a   Goland, Robin ^a   Gallagher, Mary Pat ^a  

^a Department of Medicine   (United States)

Author keywords

Diabetes mellitus type 1; Genetic testing; MODY; Pediatrics

Indexed keywords

GLUCOKINASE; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; INSULIN; HNF1A PROTEIN, HUMAN;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; CHILD; COHORT ANALYSIS; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC SCREENING; HUMAN; HUMAN CELL; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SYNTHESIS; MAJOR CLINICAL STUDY; MALE; MONOGENIC DIABETES; MONOGENIC DISORDER; PRIORITY JOURNAL; RISK FACTOR; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; GENETICS; PRESCHOOL CHILD; RETROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; GLUCOKINASE; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HUMANS; INFANT; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84926208060     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12150     Document Type: Article

References (22)

1. Murphy R, Ellard S, Hattersley AT. Clinical implications of a molecular genetic classification of monogenic β-cell diabetes. Nat Clin Pract Endocrinol Metab 2008: 4: 200-213.
2. Ellard S, Bellanné-Chantelot C, Hattersley AT, EMQN MODY group. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia 2008: 51: 546-553.
3. Ledermann HM. Maturity-onset diabetes of the young at least ten times more common in Europe than previously assumed? Diabetologia 1995: 38: 1482-1496.
4. Slingerland AS. Monogenic diabetes in children and young adults: challenges for researcher, clinician and patient. Rev Endocr Metab Disord 2006: 7: 171-185.
5. Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of MODY. N Engl J Med 2001: 345: 971-980.
6. Ehtisham E, Hattersley AT, Dunger DB, Barett TG. First UK survey of pediatric type 2 diabetes and MODY. Arch Dis Child 2004: 89: 526-529.
7. Amed S, Dean HJ, Panagiotopoulos C et al. Type 2 diabetes, medication-induced diabetes, and monogenic diabetes in Canadian children. Diabetes Care 2010: 33: 786-791.
8. Hattersley AT, Bruining J, Shield J, Njolstad P, Donaghue KC. The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes 2009: 10: 33-42.
9. Moller AM, Dalgaard LT, Pociot F, Nerup J, Hansen T, Pedersen O. Mutations in the hepatocyte nuclear factor-1α gene in Caucasian families originally classified as having type 1 diabetes. Diabetologia 1998: 41: 1528-1531.
10. Kawasaki E, Sera Y, Yamakawa K et al. Identification and functional analysis of mutations in the hepatocyte nuclear factor-1α gene in anti-islet autoantibody-negative Japanese patients. J Clin Endocrinol Metab 2000: 85: 331-335.
11. Lambert AP, Ellard S, Allen LI et al. Identifying hepatic nuclear factor 1α mutations in children and young adults with a clinical diagnosis of type 1 diabetes. Diabetes Care 2003: 26: 333-337.
12. Rubio-Cabezas O, Edghill EL, Argente J, Hattersley AT. Testing for monogenic diabetes among children and adolescents with antibody-negative clinically defined type 1 diabetes. Diabet Med 2009: 26: 1070-1074.
13. Yamada S, Nishigori H, Onda H et al. Identification of mutations in the hepatocyte nuclear factor-1 alpha gene in Japanese subjects with IDDM. Diabetes 1997: 46: 1643-1647.
14. Bonfanti R, Colombo C, Nocerino V et al. Insulin gene mutations as cause of diabetes in children negative for five type 1 diabetes autoantibodies. Diabetes Care 2009: 32: 123-129.
15. Molven A, Ringdal M, Nordbo AM et al. Mutations in the insulin gene can cause MODY and autoantibody-negative type 1 diabetes. Diabetes Care 2008: 57: 1131-1135.
16. Besser REJ, Shepherd MH, McDonald TJ et al. Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-α/hepatocyte nuclear factor 4-α maturity-onset diabetes of the young from long-duration type 1 diabetes. Diabetes Care 2011: 34: 286-291.
17. Hanukoglu A, Mizrachi A, Dalal I et al. Extrapancreatic autoimmune mcanifestations in type 1 diabetes patients and their first-degree relatives. Diabetes Care 2003: 26: 1235-1240.
18. Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 2001: 358: 221-229.
19. White RD, Harris GD. Case study: "Birds of a feather flock together": type 1a diabetes and other autoimmune disease states. Clin Diabetes 2006: 24: 40-43.
20. Hekkala A, Reunanen A, Koski M, Knip M, Veijola R, Finnish Pediatric Diabetes Register. Age-related differences in the frequency of ketoacidosis at diagnosis of type 1 diabetes in children and adolescents. Diabetes Care 2010: 33: 1500-1502.
21. Neu A, Willasch A, Ehehalt S, Hub R, Ranke M, on behalf of DIARY group Baden-Wuerttemberg. Ketoacidosis at onset of type 1 diabetes mellitus in children-frequency and clinical presentation. Pediatr Diabetes 2003: 4: 77-81.
22. McDonald TJ, Colclough K, Brown R et al. Islet autoantibodies can discriminate maturity-onset diabetes of the young (MODY) from type 1 diabetes. Diabet Med 2011: 28: 1028-1033.